Avicenna Holdings Ltd.

Avicenna Holdings Ltd. is the largest independently owned pharmacy support group in the UK, providing operational and strategic procurement services tailored to the needs of independent pharmacies. Founded in 2013 and headquartered in London, UK, Avicenna Holdings Ltd. focuses on delivering tailored operational support to independent pharmacies.

The company was acquired by Juno Health Limited in July 2019, completing the deal in September 2019. The co-founders, Jonathan Power and Kamran Yousefi, have extensive experience in the pharmaceutical sector, contributing to the company's operational strategy. Avicenna operates as the UK's largest independently owned pharmacy support group, primarily offering a range of operational and buying support services tailored for independent pharmacies. Their core product offerings include strategic procurement solutions and operational guidance designed to enhance pharmacy efficiency and profitability.

Avicenna’s services aim to address the challenges faced by pharmacy managers and owners, ensuring they can deliver high-quality patient care while achieving their business objectives. The organization serves a diverse client base of independent pharmacists across the United Kingdom, focusing on enhancing their operational capabilities and fostering a supportive community. By leveraging their extensive industry knowledge, Avicenna empowers pharmacies to navigate complex governance and operational landscapes effectively, providing invaluable support during challenging times. In the most recent year, Avicenna generated a revenue of USD 8.

43 mn and achieved an EBITDA of USD 203,842. The company's revenue model is structured primarily around membership and partnership agreements with independent pharmacies, facilitating transactions between pharmacies and suppliers for cost-saving procurement strategies. Avicenna Holdings Ltd. aims to enhance its service offerings by designing new products that will be launched in the near future, with specific timelines yet to be announced.

The company is actively exploring opportunities to expand into new markets, particularly targeting regions with a growing number of independent pharmacies. Recent funding from the acquisition by Juno Health Limited will be utilized to support these expansion initiatives and the development of new products, providing additional resources for operational improvements and market development.